June 13, 2025 - 14:31
A UC Berkeley psychologist, Keanan Joyner, advocates for a contemporary approach to evaluating psychopathic traits, suggesting that the current checklist, dating back to the 1970s, is outdated. Joyner emphasizes that by refining the criteria used to assess psychopathy, there is potential not only to improve the accuracy of diagnoses but also to significantly lessen the financial burden on the U.S. criminal justice system.
Currently, the economic impact of psychopathy on the system is staggering, estimated at $460 billion annually. This figure encompasses costs related to incarceration, rehabilitation, and recidivism, all of which could be mitigated through more effective identification and treatment of individuals exhibiting psychopathic behaviors.
Joyner’s call for an updated measurement tool reflects a growing recognition of the need for innovation in psychological assessments, aiming to enhance both public safety and the efficiency of legal processes. By adopting a more modern framework, the hope is to facilitate better outcomes for both individuals and society at large.
September 12, 2025 - 12:28
Unveiling Hidden Insights: AI and the Psychology of SpeechPsychologists are increasingly leveraging artificial intelligence to delve deeper into the nuances of human communication. By analyzing various elements of speech, including word choice, tone, and...
September 11, 2025 - 23:51
The Dark Side of Human Behavior: Understanding Sadism and Everyday CrueltyRecent research has shed light on the unsettling relationship between sadism and everyday acts of cruelty, including online trolling and bullying. This study suggests that sadism should be...
September 11, 2025 - 01:49
Unveiling Personality Through Language: The Role of AI in PsychologyWords are windows into the brain. The way individuals express themselves can reveal significant insights into their personalities and mental health, according to psychologist Josh Oltmanns from...
September 10, 2025 - 02:05
Antidepressants and Violence: Debunking the MythsAntidepressants are a mainstay of psychiatric care, and for good reason. Recent studies have reinforced the understanding that selective serotonin reuptake inhibitors (SSRIs), a common class of...